More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Madison Burgess turned to Ozempic for weight loss in 2023. She saw quick results but developed severe side effects when her dose increased. Switching to microdosing, she ultimately lost 60 lbs.

Many patients with overweight or obesity discontinue GLP-1 receptor agonist therapy within 1 year, with higher discontinuation rates seen for those without type 2 diabetes.

CardCash.com to Offer Cost-Effective Solutions for High-Demand GLP-1 Medications as Prescription Drug Market Grows SCHAUMBURG, IL / ACCESS ...

Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...

A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol ...

The quick answer is, it's complicated. Number one, quality. Number three, delay of the product. because it's no longer ...

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...

In this edition of The People's Pharmacy, Joe and Teresa Graedon also hear from a reader who's worried about using petroleum jelly.

A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...

Dr. Corey L. Hartman tells ESSENCE how this prescription can have long-term effects not just the body—but also on our skin.